Akèy › Kolestewòl
Etid klinik pou Kolestewòl ap rekrite nan Etazini
22 etid pou Kolestewòl ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC6 etid
- Hialeah, FL5 etid
- Durham, NC4 etid
- Jacksonville, FL4 etid
- Deltona, FL4 etid
- Richmond, VA4 etid
- Clearwater, FL4 etid
- Alexandria, VA3 etid
- Salt Lake City, UT3 etid
- Winston-Salem, NC3 etid
- Wichita, KS3 etid
- Houston, TX3 etid
- Chicago, IL3 etid
- St. Louis, MO3 etid
- New York City, NY3 etid
- Dallas, TX3 etid
Pa eta
- Alabama5 etid
- Arizona3 etid
- Florid7 etid
- Georgia4 etid
- Illinois4 etid
- Indiana3 etid
- Kalifòni6 etid
- Kansas3 etid
- Kentucky3 etid
- Lwizyàn4 etid
- Maryland4 etid
- Missouri4 etid
- New York5 etid
- North Carolina7 etid
- Ohio3 etid
- Oklahoma3 etid
- Oregon3 etid
- Pennsylvania4 etid
- South Carolina4 etid
- Tennessee3 etid
- Texas6 etid
- Utah3 etid
- Virginia5 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
Ap rekrite
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT06743659Causes and Natural History of Dyslipidemias
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 29, 2026 · NCT00353782Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07491172A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Sep 10, 2026 · NCT07619131Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07799961A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 30, 2026 · NCT07610278Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Jul 17, 2026 · NCT06451770Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
Ap rekrite
Laj 18 a 60 · Tout sèks · Mizajou Jul 16, 2026 · NCT06988462Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
Ap rekriteVolontè an sante akeyi
Laj 18 a 74 · Tout sèks · Mizajou Apr 17, 2026 · NCT07514663Pharmacogenomic Informed Statin Prescribing
Ap rekrite
Laj 40 a 75 · Tout sèks · Mizajou Apr 13, 2026 · NCT06568601Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
Ap rekriteVolontè an sante akeyi
Laj 18 a 39 · Tout sèks · Mizajou Mar 23, 2026 · NCT06894004Multicomponent Intervention Study- Blood Donors With High Cholesterol
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Mar 17, 2026 · NCT05693701Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Ap rekriteFaz 2
Laj 40 a 75 · Tout sèks · Mizajou Feb 27, 2026 · NCT06488105Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jan 29, 2026 · NCT06374277FELLAShip to Better Health
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jan 22, 2026 · NCT07220213HoFH, the International Clinical Collaborators Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Dec 18, 2025 · NCT04815005Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 69 · Tout sèks · Mizajou Oct 1, 2025 · NCT06747000Alirocumab in Patients on a Stable Dialysis Regimen
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Feb 12, 2020 · NCT03480568Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.